Literature DB >> 18311977

Efficient amide-directed catalytic asymmetric hydroboration.

Sean M Smith1, Nathan C Thacker, James M Takacs.   

Abstract

A series of acyclic beta,gamma-unsaturated amides are shown to undergo highly regio- (>95%) and enantioselective (93-99% ee) rhodium-catalyzed hydroboration with pinacolborane (PinBH) using simple chiral monophosphite or phosphoramidite ligands in combination with Rh(nbd)2BF4. The most effective ligands identified are phosphoramidite 4, derived from BINOL and N-methylaniline, and phosphite 5c, prepared from the (4'-tert-butyl)phenyl TADDOL analogue and phenol. For example, (E)-3-hexenoic acid phenylamide ((E)-1) undergoes rhodium-catalyzed hydroboration with PinBH (0.5 mol % Rh(nbd)2BF4, 1.1 mol % BINOL-derived phosphoramidite 4, THF, 40 degrees C, 2 h) affording an intermediate boronate ester which after oxidation with basic hydrogen peroxide gives the beta-hydroxy amide, (S)-3-hydroxyhexanoic acid phenylamide ((S)-3), in good yield (80%) and high enantiomeric purity (99% ee). Isomeric disubstituted (E)- and (Z)-alkenes give nearly identical results, and a trisubstituted alkene substrate is also shown to undergo efficient hydroboration (97% ee). Moderate catalyst loading (0.5 mol %) and reaction temperatures in 25-40 degrees C range are generally effective. N-Phenyl amides are generally more efficient than the corresponding N-benzyl or N,N-dibenzyl analogues. Pinacolborane is found to be more efficient than catecholborane.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18311977     DOI: 10.1021/ja710492q

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  19 in total

1.  Enantioselective desymmetrization via carbonyl-directed catalytic asymmetric hydroboration and Suzuki-Miyaura cross-coupling.

Authors:  Gia L Hoang; Zhao-Di Yang; Sean M Smith; Rhitankar Pal; Judy L Miska; Damaris E Pérez; Libbie S W Pelter; Xiao Cheng Zeng; James M Takacs
Journal:  Org Lett       Date:  2015-02-02       Impact factor: 6.005

2.  γ-Selective directed catalytic asymmetric hydroboration of 1,1-disubstituted alkenes.

Authors:  Sean M Smith; Gia L Hoang; Rhitankar Pal; Mohammad O Bani Khaled; Liberty S W Pelter; Xiao Cheng Zeng; James M Takacs
Journal:  Chem Commun (Camb)       Date:  2012-12-28       Impact factor: 6.222

3.  Remarkable levels of enantioswitching in catalytic asymmetric hydroboration.

Authors:  Sean M Smith; James M Takacs
Journal:  Org Lett       Date:  2010-10-15       Impact factor: 6.005

4.  Catalytic acceptorless dehydrogenations: Ru-Macho catalyzed construction of amides and imines.

Authors:  Nathan J Oldenhuis; Vy M Dong; Zhibin Guan
Journal:  Tetrahedron       Date:  2014-07-08       Impact factor: 2.457

5.  Surprisingly Facile C-H Activation in the Course of Oxime-Directed Catalytic Asymmetric Hydroboration.

Authors:  Nathan C Thacker; Veronika M Shoba; Andrew E Geis; James M Takacs
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

6.  Diastereoselective Ni-catalyzed 1,4-hydroboration of chiral dienols.

Authors:  Robert J Ely; Zhiyong Yu; James P Morken
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

7.  Ruthenium-Catalyzed Amination of Secondary Alcohols using Borrowing Hydrogen Methodology.

Authors:  Kostiantyn O Marichev; James M Takacs
Journal:  ACS Catal       Date:  2016-02-23       Impact factor: 13.084

8.  Amide-directed catalytic asymmetric hydroboration of trisubstituted alkenes.

Authors:  Sean M Smith; James M Takacs
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

9.  Directed, Palladium(II)-Catalyzed Enantioselective anti-Carboboration of Alkenyl Carbonyl Compounds.

Authors:  Zhen Liu; Xiaohan Li; Tian Zeng; Keary M Engle
Journal:  ACS Catal       Date:  2019-03-13       Impact factor: 13.084

10.  Rhodium-catalyzed asymmetric hydroboration of γ,δ-unsaturated amide derivatives: δ-borylated amides.

Authors:  G L Hoang; S Zhang; J M Takacs
Journal:  Chem Commun (Camb)       Date:  2018-05-08       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.